Hollander, P. Et Al. 2015. Insulin degludec improves long-term glycaemic control similarly to insulin glargine but with fewer hypoglycaemic episodes in patients with advanced type 2 diabetes on basal-bolus insulin therapy. DIABETES OBESITY & METABOLISM , vol.17, no.2 , 202-206.

Hollander, P., King, A. B., Del Prato, S., Sreenan, S., BALCI, M. K., Munoz-Torres, M., ... Rosenstock, J.(2015). Insulin degludec improves long-term glycaemic control similarly to insulin glargine but with fewer hypoglycaemic episodes in patients with advanced type 2 diabetes on basal-bolus insulin therapy. DIABETES OBESITY & METABOLISM , vol.17, no.2, 202-206.

Hollander, P. Et Al. "Insulin degludec improves long-term glycaemic control similarly to insulin glargine but with fewer hypoglycaemic episodes in patients with advanced type 2 diabetes on basal-bolus insulin therapy," DIABETES OBESITY & METABOLISM , vol.17, no.2, 202-206, 2015

Hollander, P. Et Al. "Insulin degludec improves long-term glycaemic control similarly to insulin glargine but with fewer hypoglycaemic episodes in patients with advanced type 2 diabetes on basal-bolus insulin therapy." DIABETES OBESITY & METABOLISM , vol.17, no.2, pp.202-206, 2015

Hollander, P. Et Al. (2015) . "Insulin degludec improves long-term glycaemic control similarly to insulin glargine but with fewer hypoglycaemic episodes in patients with advanced type 2 diabetes on basal-bolus insulin therapy." DIABETES OBESITY & METABOLISM , vol.17, no.2, pp.202-206.

@article{article, author={P. Hollander Et Al. }, title={Insulin degludec improves long-term glycaemic control similarly to insulin glargine but with fewer hypoglycaemic episodes in patients with advanced type 2 diabetes on basal-bolus insulin therapy}, journal={DIABETES OBESITY & METABOLISM}, year=2015, pages={202-206} }